Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4726 | 1662 | 36.9 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
132 | 22818 | ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ALISKIREN | Author keyword | 251 | 66% | 14% | 234 |
2 | PRORENIN RECEPTOR | Author keyword | 120 | 74% | 5% | 89 |
3 | DIRECT RENIN INHIBITOR | Author keyword | 97 | 80% | 4% | 60 |
4 | RENIN INHIBITOR | Author keyword | 83 | 57% | 6% | 98 |
5 | RENIN INHIBITORS | Author keyword | 51 | 64% | 3% | 50 |
6 | PRORENIN | Author keyword | 43 | 37% | 6% | 92 |
7 | RENIN INHIBITION | Author keyword | 30 | 59% | 2% | 34 |
8 | DIRECT RENIN INHIBITORS | Author keyword | 27 | 78% | 1% | 18 |
9 | PRO RENIN RECEPTOR | Author keyword | 27 | 92% | 1% | 11 |
10 | RENIN | Author keyword | 26 | 10% | 14% | 238 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALISKIREN | 251 | 66% | 14% | 234 | Search ALISKIREN | Search ALISKIREN |
2 | PRORENIN RECEPTOR | 120 | 74% | 5% | 89 | Search PRORENIN+RECEPTOR | Search PRORENIN+RECEPTOR |
3 | DIRECT RENIN INHIBITOR | 97 | 80% | 4% | 60 | Search DIRECT+RENIN+INHIBITOR | Search DIRECT+RENIN+INHIBITOR |
4 | RENIN INHIBITOR | 83 | 57% | 6% | 98 | Search RENIN+INHIBITOR | Search RENIN+INHIBITOR |
5 | RENIN INHIBITORS | 51 | 64% | 3% | 50 | Search RENIN+INHIBITORS | Search RENIN+INHIBITORS |
6 | PRORENIN | 43 | 37% | 6% | 92 | Search PRORENIN | Search PRORENIN |
7 | RENIN INHIBITION | 30 | 59% | 2% | 34 | Search RENIN+INHIBITION | Search RENIN+INHIBITION |
8 | DIRECT RENIN INHIBITORS | 27 | 78% | 1% | 18 | Search DIRECT+RENIN+INHIBITORS | Search DIRECT+RENIN+INHIBITORS |
9 | PRO RENIN RECEPTOR | 27 | 92% | 1% | 11 | Search PRO+RENIN+RECEPTOR | Search PRO+RENIN+RECEPTOR |
10 | RENIN | 26 | 10% | 14% | 238 | Search RENIN | Search RENIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RENIN PRORENIN RECEPTOR | 225 | 82% | 8% | 133 |
2 | NONPROTEOLYTIC ACTIVATION | 171 | 78% | 7% | 112 |
3 | PRORENIN RECEPTOR | 126 | 68% | 7% | 110 |
4 | ALISKIREN | 111 | 55% | 8% | 140 |
5 | RO 42 5892 | 89 | 92% | 2% | 35 |
6 | PLACEBO LIKE TOLERABILITY | 88 | 89% | 2% | 40 |
7 | RENIN INHIBITOR ALISKIREN | 87 | 73% | 4% | 67 |
8 | HANDLE REGION PEPTIDE | 84 | 87% | 2% | 41 |
9 | DOSE DEPENDENT EFFICACY | 77 | 89% | 2% | 34 |
10 | EXHIBITS SIMILAR PHARMACOKINETICS | 72 | 100% | 1% | 23 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Renin, (pro)renin and receptor: an update | 2011 | 47 | 74 | 77% |
The Biology of the (Pro)Renin Receptor | 2010 | 64 | 40 | 88% |
The (pro)renin receptor. A decade of research: what have we learned? | 2013 | 10 | 98 | 77% |
Aliskiren: the first renin inhibitor for clinical treatment | 2008 | 111 | 64 | 66% |
Oral renin inhibitors | 2006 | 143 | 64 | 83% |
RENIN INHIBITORS | 1990 | 274 | 154 | 53% |
Clinical pharmacokinetics and pharmacodynamics of Aliskiren | 2008 | 64 | 37 | 78% |
Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents | 2008 | 51 | 48 | 90% |
(Pro)renin and its receptors: pathophysiological implications | 2012 | 14 | 127 | 69% |
Intracardiac intracellular angiotensin system in diabetes | 2012 | 17 | 84 | 61% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOL VASC MED | 11 | 46% | 1.1% | 18 |
2 | UNIT 833 | 11 | 100% | 0.4% | 6 |
3 | VASC PHARMACOL METAB | 5 | 60% | 0.4% | 6 |
4 | ENDOCRINOL PL MED SCI | 5 | 36% | 0.7% | 12 |
5 | SYNTHET WELF | 4 | 39% | 0.5% | 9 |
6 | MED ENDOCRINOL HYPERTENS 2 | 3 | 57% | 0.2% | 4 |
7 | ANTIAGING MED ENDOCRINOL | 3 | 100% | 0.2% | 3 |
8 | ENDOCRINOL ANTIAGING MED INTERNAL MED | 3 | 100% | 0.2% | 3 |
9 | ENDOCRINOL ANTIAGING MED | 3 | 60% | 0.2% | 3 |
10 | MOL BIOCHEM HYPERTENS | 3 | 25% | 0.5% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000150553 | ADRENAL RENIN//ANGIOTENSINOGEN//TISSUE RENIN |
2 | 0.0000149084 | INACTIVE RENIN//PRORENIN//RENIN |
3 | 0.0000137334 | HYPERTENS RENAL EXCELLENCE//URINARY ANGIOTENSINOGEN//RECEPTOR SIGNAL TRANSDUCT |
4 | 0.0000131651 | OCULAR RENIN ANGIOTENSIN SYSTEM//REN 2 RAT//S PHARMACOL MOL BIOL |
5 | 0.0000092067 | PREUSSIN//HAPALOSIN//ALPHA AMINO ALDEHYDES |
6 | 0.0000071685 | ANGIOTENSIN 1 7//ANGIOTENSIN CONVERTING ENZYME 2//MAS RECEPTOR |
7 | 0.0000060842 | CANDESARTAN CILEXETIL//ANGIOTENSIN II RECEPTOR ANTAGONIST//LOSARTAN |
8 | 0.0000057802 | PATOL VASC NEFROL EXPT//VASC RENAL PATHOL//MED ALFREDO LANARI |
9 | 0.0000054259 | DUAL BLOCKADE//RENOPROTECTION//NONDIABETIC RENAL DISEASE |
10 | 0.0000049883 | TELMISARTAN//ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER//CLIN TRIAL MANAGEMENTITABASHI KU |